The effect of COVID-19 pandemic on diabetes care indices in Southern Iran: an interrupted time series analysis.
COVID-19
Diabetes care
Type 2 diabetes
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
13 Feb 2023
13 Feb 2023
Historique:
received:
17
10
2021
accepted:
07
02
2023
entrez:
14
2
2023
pubmed:
15
2
2023
medline:
16
2
2023
Statut:
epublish
Résumé
Type 2 diabetes mellitus (T2DM) requires a continues bulk of cares. It is very probable COVID-19 pandemic is affected its healthcare coverage. The interrupted time series analysis is used to model the trend of diabetes healthcare indices, such as the health worker visits, physician visits, body mass index (MBI), fasting blood sugar (FBS), and hemoglobin A1c (HbA1c), before and after the start of COVID-19 pandemic. The reference of data was the totals of all T2DM patients living in Fars Province, Southern Iran, areas covered by Shiraz University of Medical Science (SUMS), from 2019 to 2020. A significant decrease for visits by the health workers, and physicians was observed by starting COVID-19 pandemic (β When the COVID-19 pandemic was announced, T2DM healthcare coverage drastically decreased, but it quickly began to rebound. The health monitoring system could not have any noticeable effects on diabetes outcomes.
Sections du résumé
BACKGROUND
BACKGROUND
Type 2 diabetes mellitus (T2DM) requires a continues bulk of cares. It is very probable COVID-19 pandemic is affected its healthcare coverage.
METHODS
METHODS
The interrupted time series analysis is used to model the trend of diabetes healthcare indices, such as the health worker visits, physician visits, body mass index (MBI), fasting blood sugar (FBS), and hemoglobin A1c (HbA1c), before and after the start of COVID-19 pandemic. The reference of data was the totals of all T2DM patients living in Fars Province, Southern Iran, areas covered by Shiraz University of Medical Science (SUMS), from 2019 to 2020.
RESULTS
RESULTS
A significant decrease for visits by the health workers, and physicians was observed by starting COVID-19 pandemic (β
CONCLUSIONS
CONCLUSIONS
When the COVID-19 pandemic was announced, T2DM healthcare coverage drastically decreased, but it quickly began to rebound. The health monitoring system could not have any noticeable effects on diabetes outcomes.
Identifiants
pubmed: 36782171
doi: 10.1186/s12913-023-09158-4
pii: 10.1186/s12913-023-09158-4
pmc: PMC9925215
doi:
Substances chimiques
Glycated Hemoglobin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
148Informations de copyright
© 2023. The Author(s).
Références
J Gen Intern Med. 2021 May;36(5):1460-1462
pubmed: 33469742
Cell Metab. 2020 Jun 2;31(6):1068-1077.e3
pubmed: 32369736
JMIR Diabetes. 2020 May 15;5(2):e19581
pubmed: 32392473
Arch Iran Med. 2020 Aug 01;23(8):564-567
pubmed: 32894970
BMJ Open Diabetes Res Care. 2018 Dec 06;6(1):e000541
pubmed: 30613400
Obes Med. 2022 Aug;33:100418
pubmed: 35664969
Acad Pediatr. 2013 Nov-Dec;13(6 Suppl):S38-44
pubmed: 24268083
Diabetes Care. 2021 Jan;44(1):e18-e21
pubmed: 33127611
Diabetes Care. 2003 Jan;26 Suppl 1:S33-50
pubmed: 12502618
Diabetes Res Clin Pract. 2021 Jun;176:108840
pubmed: 33933499
Diabetes Res Clin Pract. 2020 Aug;166:108304
pubmed: 32623040
Diabetes Obes Metab. 2021 Jul;23(7):1624-1630
pubmed: 33764666
BMJ Open. 2014 Apr 17;4(4):e004100
pubmed: 24742975
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1815-1819
pubmed: 32956926
Iran J Med Sci. 2019 May;44(3):204-213
pubmed: 31182886
BMC Public Health. 2011 Jul 14;11:564
pubmed: 21756350
Heliyon. 2021 Jun 09;7(6):e07260
pubmed: 34179534
Lancet. 2011 Jul 2;378(9785):31-40
pubmed: 21705069
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1579-1584
pubmed: 32858476
Diabetes Care. 2020 Jul;43(7):1399-1407
pubmed: 32409498
Prim Care Diabetes. 2021 Dec;15(6):918-922
pubmed: 34393092
BMJ Open. 2022 Oct 26;12(10):e059983
pubmed: 36288832
J Adolesc Health. 2020 Oct;67(4):615-617
pubmed: 32798101
Prim Care Diabetes. 2021 Jun;15(3):424-427
pubmed: 33441263
Eur J Endocrinol. 2020 Aug;183(2):G67-G77
pubmed: 32508313
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):965-967
pubmed: 32604016